Sun Pharma to launch Brillo, a first-in-class oral lipid-lowering drug in India
Bempedoic Acid administered as a 180-mg dose, is approved by the USFDA and European Union for the treatment of hypercholesterolemia
Bempedoic Acid administered as a 180-mg dose, is approved by the USFDA and European Union for the treatment of hypercholesterolemia
Tirzepatide is primarily indicated for the treatment of T2D and is expected to receive its decision from the FDA in Q2 2022
A seasoned professional, he will lead the strategy and business operations of Cadila’s branded prescriptions pharma business
For the first time in India – fast, precise and efficient calibration of multi-channel micropipettes
Boehringer Ingelheim continues to innovate to enhance the customer experience and improve animal health and well-being
“We are committed to making India a global medical value hub by further strengthening our traditional medicine industry and boosting 'Heal in India' & 'Heal by India'
Cipla has reported consolidated financial results for the period ended March 31, 2022
HK inno.N Corporation will be responsible for the manufacture and supply of Tegoprazan, while Dr. Reddy's will handle local clinical development, registration, marketing and sales
Company's net income rose by 57.5 percent to 3.291 billion euros in Q1
Myovant to receive an upfront payment of US $50 million, is eligible to receive commercial launch, sales-based and other milestones totaling up to US $90.5 million
Subscribe To Our Newsletter & Stay Updated